CLOSE
Identifying 3D objects
ICFO and ICREA
Filing date: 9 Dec, 2020
Licenced date: 9 Dec, 2020
EP20383072.4
ICREA selects researchers based solely on their scientific achievements. However, excellent science often leads to the invention of new and amazing technologies and solutions. When that happens, ICREA fully supports the exploitation of these opportunities.
Our ICREA research professors are working in different Universities and Research Centres. On account of this, ownership of any intellectual or industrial property is always shared between ICREA and the host institution. To make negotiations as fast and conclusive as possible, host institutions are entitled to explore and engage in technology transfer activities on behalf of ICREA when opportunities arise. ICREA supports the exploitation efforts and offers advice throughout the process.
Please have a look at our current technologies and contact ICREA to learn more about them.
-
CLOSE
Chimeric antigen receptors specific for P95HER2 and uses thereof
La presente invención se refiere a un receptor de antígeno quimérico (CAR) capaz de 5 dirigirse a células que expresan p95HER2. La invención también se refiere a un fragmento variable de cadena sencilla (ScFv), a un dominio de unión a antígeno y a un anticuerpo o fragmento de anticuerpo del mismo capaz de unirse al antígeno p95HER2. Además, la presente invención se refiere a un conjugado anticuerpo-fármaco (ADC) que comprende un agente terapéutico y un anticuerpo o dominio de unión a antígeno 10 específico para p95HER2. La invención también se refiere a un método de diagnóstico de cáncer y a una composición farmacéutica para su uso en un método de prevención o tratamiento del cáncer que comprenden el CAR y/o el dominio de unión a antígeno o el anticuerpo de la invención.
VHIO
Filing date: 12 Jun, 2020
Licenced date: 11 Dec, 2020
EP20382457.8
-
CLOSE
CD22 Targeting-moiety for the treatment of B-cell acute lymphoblastic Leukemia (B-ALL).
The present invention provides therapeutics for the treatment of CD22-positive cancers such as B-cell acute lymphoblastic eukemia (B-ALL). In particular, the present invention provides an anti-CD22 monoclonal antibody whose F(AB')2, particularly the scFv fragment, can target the CD22 antigen, for use in the treatment of CD22-positive cancers.
IJC
Filing date: 11 Mar, 2020
Licenced date: 16 Jul, 2020
EP20382175.6
-
CLOSE
Pulmobiotics
TM - Extended to US within priority period (before 14/08) / Licensed to Pulmobiotics S.L.
Center for Genomic Regulation
Filing date: 14 Feb, 2020
Licenced date: 14 Aug, 2020
018196643
-
CLOSE
Method to photo-capture CO2 with perovskite oxide compounds
The present application refers to a method for CO2 capture wherein light, particularly ultraviolet illumination, greatly improves the amount of CO2 captured on engineered perovskite oxide compounds. By a photorefractive phenomenon under near ultraviolet illumination, ionized defects are created at the surface of B-site defective oxide perovskites which act as additional CO2 trapping centres. The present method can be implemented at a temperature between -10ºC and 80ºC, and is cyclable, i.e. the perovskite oxide compounds can be regenerated by heat and used for subsequent CO2 capture.
ICN2
Filing date: 30 Dec, 2019
PCT/EP2020/088044
-
CLOSE
Gene editing based cancer treatment
Filing date: 14 Oct, 2019
PCT/EP2019/078408
-
CLOSE
Title confidential - not published yet
ICFO
Filing date: 30 Sep, 2019
US62/908,079
-
CLOSE
A microstructured film comprising inorganic-organic hybrid polymers, a method for manufacturing thereof and a method for cooling the surface of an element by applying said microstructured film.
The present invention relates to a microstructured film comprising an inorganic-organic hybrid polymer which is capable to cool down and to keep clean the surface on which it is applied on. The present invention further relates to a method for manufacturing said microstructured film and to a method for cooling the surface of an element by applying said microstructured film.
ICN2
Filing date: 30 Jul, 2019
PCT/EP19382655/071560
-
CLOSE
Electrochemical cell device for use in a SOFC and/or a SOEC and methods for operating a SOFC or a SOEC by using thereof.
The present invention relates to the field of electrochemistry. In particular, the present invention relates to an electrochemical cell device for use in a solid oxide fuel cell (SOFC) and/or a solid oxide electrolyser cell (SOEC) mode, and to a method for operating a solid oxide fuel cell and/or a solid oxide electrolyser cell by using said electrochemical cell device.
IREC
Filing date: 18 Jun, 2019
EP19382509
-
CLOSE
FLUIDIC APPARATUS FOR OPTICAL INTERROGATION OF INDIVIDUAL MICROORGANISMS
Filing date: 18 Apr, 2019
PCT/ES2019/070270